by on
The patient developed this cutaneous adverse reaction 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication? A). Epidermal growth factor receptor (EGFR) inhibitor B.) Tumor necrosis factor (TNF)-alpha inhibitor C.) Smoothened inhibitor D.) BRAF inhibitor E.) Programmed cell death (PD)-1 inhibitor To find out the correct answer a …
The patient developed this cutaneous adverse reaction 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication? A). Epidermal growth factor receptor (EGFR) inhibitor B.) Tumor necrosis factor (TNF)-alpha inhibitor C.) Smoothened inhibitor D.) BRAF inhibitor E.) Programmed cell death (PD)-1 inhibitor To find out the correct answer a …
Continue reading "Cutaneous Adverse Reaction – Friday Pop Quiz – 11/16"
